Delivery Order SPE2DB20D1100-SPE2DB25FD9J2
- Not listed
- The Defense Logistics Agency awarded a $7,910.13 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication prescribed to prevent nausea and vomiting,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,576.33 for Ondansetron ODT 4 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal...
- The Defense Logistics Agency awarded a $2,232.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, non-set-aside contract calls for performance at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a ceiling value of $13,483.05. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-set-aside, competitively awarded contract. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $4,094.19 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count quantity. This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication...
- The Defense Logistics Agency awarded a delivery order valued at $35,959.67 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500 count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a widely used antiemetic medication commonly prescribed to...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.80 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea...
- The Defense Logistics Agency awarded a $2,586.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of July 30, 2025. This non-set-aside contract was competitively awarded on July 29, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $7,523.67 for Ondansetron ODT 4 mg tablets (30-count package), with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Ondansetron is a standard antiemetic medication commonly used in military and veteran healthcare settings to...
- The Defense Logistics Agency awarded a $5,630.06 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract is classified as a firm fixed price delivery order and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9J2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,966.12 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This contract, executed on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price transaction with no set-aside designation, indicating competitive award status. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication prescribed to prevent nausea and vomiting, particularly in military and veteran healthcare settings. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supports global pharmaceutical procurement for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, maintains an extensive portfolio of pharmaceutical and medical supply delivery orders with the Defense Logistics Agency, serving defense and civilian healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's consistent selection through competitive procurement processes demonstrates its capability to meet federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/7/25 |